Mary Jo Caranfa
- Molecular Biology top 5%
- Oncology top 5%
- Organic Chemistry top 5%
- Toxicology top 0.2%
- Pharmacology top 5%
- Co-authors
- Robert HertzbergSidney M. HechtKenneth G. HoldenRandall K. JohnsonWilliam D. KingsburyGregory GallagherDalia R. JakasJeffrey C. Boehm
- Topics
- Cancer therapeutics and mechanisms (6 papers)DNA and Nucleic Acid Chemistry (5 papers)Bioactive Compounds and Antitumor Agents (3 papers)
- Cited by
- ToxicologyOncologyMolecular Biology
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Mary Jo Caranfa
11 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 1.5k
- Oncology 748
- Organic Chemistry 446
- Toxicology 393
- Pharmacology 305
Countries citing papers authored by Mary Jo Caranfa
This map shows the geographic impact of Mary Jo Caranfa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Jo Caranfa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Jo Caranfa more than expected).
Fields of papers citing papers by Mary Jo Caranfa
This network shows the impact of papers produced by Mary Jo Caranfa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Jo Caranfa. The network helps show where Mary Jo Caranfa may publish in the future.
Co-authorship network of co-authors of Mary Jo Caranfa
This figure shows the co-authorship network connecting the top 25 collaborators of Mary Jo Caranfa. A scholar is included among the top collaborators of Mary Jo Caranfa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Jo Caranfa. Mary Jo Caranfa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 339 | |
| 2 | 444 | |
| 3 | 1 | |
| 4 | 89 | |
| 5 | 482 | |
| 6 | 366 | |
| 7 | 23 | |
| 8 | Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I. | 113 |
| 9 | 21 | |
| 10 | 1 | |
| 11 | 9 | |
| 12 | 11 |
About Mary Jo Caranfa
Mary Jo Caranfa is a scholar working on Toxicology, Molecular Medicine and Molecular Biology, having authored 12 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (6 papers), DNA and Nucleic Acid Chemistry (5 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Toxicology (393 citations), Oncology (748 citations) and Molecular Biology (1.5k citations). Mary Jo Caranfa has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Robert Hertzberg, Sidney M. Hecht, Kenneth G. Holden, Randall K. Johnson, William D. Kingsbury, Gregory Gallagher, Dalia R. Jakas, Jeffrey C. Boehm, Francis L. McCabe and Leo F. Faucette. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.